← Ticker index
ABT
Ticker
ABT
Congressional Trades
197
by 23 members
Ticker disclosure brief
Congressional disclosure records for ABT
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Rick Larsen
SELL · 2026-07-08
Largest range
$250K – $500K
Tina Smith
Longest observed gap
132d
Rick Larsen
Highest 30d vs SPY
9.1%
Julie Johnson
Purchase rows
90
46%
Sale rows
100
51%
Disclosed midpoint
$3.8M
range estimate
Unique Traders
23
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats122 · 62%
Republicans75 · 38%
Federal awards
all →- 2026-07-07$31KDepartment of Veterans AffairsLVAD SUPPLIES
- 2026-07-01$2.4MDepartment of Veterans AffairsPURCHASE OF COST PER REPORTABLE RESULT LABORATORY SUPPLIES
- 2026-07-01$102KDepartment of Veterans AffairsWHOLE BLOOD GLUCOSE MONITORING
- 2026-07-01$20KDepartment of Health and Human ServicesU&C BRIDGE CONTRACT IMMUNOASSAY REAGENTS, SUPPLIES, AND ANALYZER SUPPORT SERVICES POP FOR 6 MONTHS AFTER AWARD AT STANDING ROCK FORT YATES, ND
- 2026-07-01$0Department of Veterans AffairsVISN 8 WHOLE BLOOD GLUCOSE MONITORING
- 2026-06-30$280KDepartment of Veterans AffairsCPRR INFECTIOUS DISEASE TESTING
- 2026-06-30$55KDepartment of Veterans AffairsEXECUTIVE ORDER 14398 | ABBOT ENSITE REPAIR
- 2026-06-30$5KDepartment of Veterans AffairsISTAT POINT OF CARE COST PER TEST (SAN JUAN) ADDITIONAL CARTRIDGES
- 2026-06-26$165KDepartment of Health and Human ServicesEO 14398 ALINITY MAINTENANCE AND SUPPLIES
- 2026-06-24$38KDepartment of Veterans AffairsGENERATOR
Lobbying filings
all →- 2026-07-09$60KABBOTT LABORATORIESIssues related to infant formula, including H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula. Proposals related to Medicare coverage of continuous glucose monitors. Issues related to cancer diagnostics national coverage determination. H.R.3512 - Tackling Predatory Litigation Funding Act. Issues related to TRICARE coverage of diabetes management devices.
- 2026-07-08$60KABBOTT LABORATORIESIssues related to the supply of infant formula and nutrition. Issues related to federal tax policy. Issues related to medical device reimbursement. Issues related to diagnostic testing.
- 2026-04-27$0ABBOTT LABORATORIESIssues related to commercial litigation; Issues related to pension matters. Issues related to commercial litigation; Issues related to pension matters. Issues related to commercial litigation; Issues related to pension matters. Issues related to commercial litigation; Issues related to pension matters.
- 2026-04-20$1.4MABBOTT LABORATORIESProposals to reform domestic and international tax structures. Proposals related to third party litigation reform. S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R. 9817 Toxic Free Food Act of 2024. H.R. 4958 The Grocery Reform and Safety (GRAS) Act. Proposals related to heavy metals in food. Proposals related to pension premiums and employee benefits. Proposals related to the use of the Uniform Commercial Code (UCC). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. H.R. 7118 The Genomic Answers for Children's Health Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to the coverage of continuous glucose monitors in TRICARE. Proposals to support updates to the Veteran colorectal cancer screening directive. S. 2761/H.R. 5269 The Reforming an
- 2026-04-20$60KABBOTT LABORATORIESIssues related to Japan operations.
- 2026-04-20$50KABBOTT LABORATORIESIssues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.
- 2026-04-20$0ABBOTT LABORATORIES
- 2026-04-20$0ABBOTT LABORATORIESIssues related to OECD tax negotiations.
- 2026-04-20$0ABBOTT LABORATORIES
- 2026-04-18$50KABBOTT LABORATORIESIssues related to global health policy and funding; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75). Issues related to global health policy and funding.
Loading trade analytics…
All Disclosed Trades
Page 3 · 25 of 197 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2026-01-29 | RThomas Kean | BUY | $1K – $15K | 21d | receipt → |
| 2026-01-29 | RThomas Kean | BUY | $1K – $15K | 21d | receipt → |
| 2026-01-23 | DRo Khanna | SELL | $15K – $50K | 14d | receipt → |
| 2026-01-29 | DRo Khanna | SELL | $15K – $50K | 8d | receipt → |
| 2026-01-22 | DRo Khanna | SELL | $1K – $15K | 15d | receipt → |
| 2026-01-22 | DRo Khanna | SELL | $15K – $50K | 15d | receipt → |
| 2026-01-23 | DRo Khanna | SELL | $15K – $50K | 14d | receipt → |
| 2026-01-22 | DRo Khanna | SELL | $15K – $50K | 15d | receipt → |
| 2026-01-29 | DRo Khanna | SELL | $15K – $50K | 8d | receipt → |
| 2026-01-22 | DRo Khanna | SELL | $1K – $15K | 15d | receipt → |
| 2025-12-18 | DJulie Johnson | SELL | $1K – $15K | 29d | receipt → |
| 2025-12-18 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-12-18 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-12-08 | RJulia Letlow | SELL | $1K – $15K | 37d | receipt → |
| 2024-10-23 | RJulia Letlow | BUY | $1K – $15K | 447dApparent delay | receipt → |
| 2025-12-08 | RJulia Letlow | SELL | $1K – $15K | 36d | receipt → |
| 2025-12-19 | DGilbert Cisneros | SELL | $1K – $15K | 25d | receipt → |
| 2025-12-08 | RJulia Letlow | SELL | $1K – $15K | 36d | receipt → |
| 2024-10-23 | RJulia Letlow | BUY | $1K – $15K | 447dApparent delay | receipt → |
| 2025-12-19 | DGilbert Cisneros | SELL | $1K – $15K | 24d | receipt → |
| 2025-12-19 | DGilbert Cisneros | SELL | $1K – $15K | 24d | receipt → |
| 2025-12-04 | RByron Donalds | SELL | $1K – $15K | 35d | receipt → |
| 2025-12-04 | RByron Donalds | SELL | $1K – $15K | 34d | receipt → |
| 2025-12-04 | RByron Donalds | SELL | $1K – $15K | 34d | receipt → |
| 2025-11-18 | DGilbert Cisneros | BUY | $1K – $15K | 28d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.